Emerging Trends in Cancer Pharmacology
From Molecular Targets to Personalized Medicine
- 1st Edition - March 1, 2026
- Editors: Tapan Behl, Shriyansh Srivastav, Sukhbir Singh, Neelam Sharma, Pranay Wal
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 1 5 9 2 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 1 5 9 3 - 0
Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine gives readers a comprehensive and up-to-date resource on the latest developments and trends… Read more
Purchase options
Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine gives readers a comprehensive and up-to-date resource on the latest developments and trends in the field of cancer pharmacology. It serves as a valuable reference for researchers, scientists, clinicians, and other professionals involved in cancer research, pharmacology, oncology, and personalized medicine. In recent years, there have been significant breakthroughs in understanding the molecular mechanisms of cancer and the development of targeted therapies. Additionally, personalized medicine has emerged as a promising approach to tailor treatments based on an individual's genetic profile, tumor characteristics, and other factors. These developments have the potential to revolutionize cancer treatment and improve patient outcomes. This book covers such developments.
- Provides a comprehensive overview of the emerging trends in cancer pharmacology, offering readers the opportunity to expand their knowledge and stay up to date with the latest advancements in the field
- For researchers and scientists, the title serves as a valuable resource for understanding the molecular targets and personalized medicine approaches in cancer pharmacology
- Provides insights into new avenues for drug discovery, development, and optimization, thereby facilitating more targeted and effective therapies
Researchers and professionals involved in the field of cancer research, pharmacology, oncology, and personalized medicine
1. Understanding Cancer: Molecular Basis and Challenges
2. Pharmacokinetics and Pharmacodynamics in Cancer Pharmacology
3. Oncogenes and Tumor Suppressor Genes
4. Signaling Pathways in Cancer
5. Immunotherapy and Immune Checkpoint Inhibitors
6. Biomarkers in Cancer Pharmacology
7. Genomics and Next-Generation Sequencing
8. Pharmacogenomics and Therapeutic Drug Monitoring
9. Targeted Therapies and Small Molecule Inhibitors
10. Nanotechnology in Cancer Pharmacology
11. Epigenetic Modulators in Cancer Therapy
12. Gene Therapy and CRISPR-Cas9 Technology
13. Role of AI in molecular cancer pharmacology
14. Combination Therapies in Cancer
15. Precision Medicine in Pediatric Oncology
16. Precision Medicine in Oral Cancer
17. Clinical Trials in Personalized Cancer Therapy
18. Drug Resistance in Cancer
19. Future Directions and Challenges in Cancer Pharmacology
2. Pharmacokinetics and Pharmacodynamics in Cancer Pharmacology
3. Oncogenes and Tumor Suppressor Genes
4. Signaling Pathways in Cancer
5. Immunotherapy and Immune Checkpoint Inhibitors
6. Biomarkers in Cancer Pharmacology
7. Genomics and Next-Generation Sequencing
8. Pharmacogenomics and Therapeutic Drug Monitoring
9. Targeted Therapies and Small Molecule Inhibitors
10. Nanotechnology in Cancer Pharmacology
11. Epigenetic Modulators in Cancer Therapy
12. Gene Therapy and CRISPR-Cas9 Technology
13. Role of AI in molecular cancer pharmacology
14. Combination Therapies in Cancer
15. Precision Medicine in Pediatric Oncology
16. Precision Medicine in Oral Cancer
17. Clinical Trials in Personalized Cancer Therapy
18. Drug Resistance in Cancer
19. Future Directions and Challenges in Cancer Pharmacology
- Edition: 1
- Published: March 1, 2026
- Language: English
TB
Tapan Behl
Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.
Affiliations and expertise
Professor, Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, IndiaSS
Shriyansh Srivastav
Shriyansh Srivastava is pursuing a PhD in Pharmacology and Clinical Research at Delhi Pharmaceutical Sciences and Research University.
Affiliations and expertise
Delhi Pharmaceutical Sciences and Research University, IndiaSS
Sukhbir Singh
Professor Sukhbir Singh has a PhD in Pharmaceutical Science and experience of more than 15 years in academia and research. He has 170 publications in various National/International journal of repute, 8 books, 12 books chapter and filed 19 patents to his credit. He has presented/published 40 review/research abstracts in various National/International conferences. His areas of interest in research are nanotechnology/liposome/niosomes/SEDDS based formulation development and solubility enhancement of BCS class II drugs. He has expertise in operation of various statistical analysis tools
Affiliations and expertise
Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, IndiaNS
Neelam Sharma
Dr. Neelam Sharma, PhD in Pharmaceutical Science has experience of more than 13 years in academics and research. She is highly self-determined and organized pharmaceutical research professional. She has 140 publications in various National/International journal of repute, h-index 12 and i 10-index 20, 08 books, 12 books chapter and filed 19 patents to his credit. She has presented/published 35 review/research abstracts in various National/International conferences. She has completed 4 consultancy projects on herbal/homeopathic formulation. She and her team received IEDC, Govt of India, prototyping grant of Rs 2.5 lacs for project related to management of ARDS in COVID, held at Chitkara University, Punjab in 2020 and project has been completed in 2022. She has guided 1 PhD students and 20 M. Pharmacy students and 6 Ph.D students are pursuing PhD under her guidance.
Affiliations and expertise
Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, IndiaPW
Pranay Wal
Professor (Dr.) Pranay Wal is working as Professor and Dean in PSIT Pharmacy Kanpur, India. He has published more than 80 Scopus / SCI Papers in national and international reputed journals and has filed more than. He is involved in medical device development with scientists from IIT Kanpur and NIPER (National Institute of Pharmaceutical Education and Research).
Affiliations and expertise
PSIT- Pranveer Singh Institute of Technology-Pharmacy, India